Table 2.

Exclusions and denominators used for prevalence estimation within evaluation time points

Time points	Schistosoma haematobium		Soil-transmitted helminths (STH)		Hymenolepis nana		Plasmodium falciparum		Anaemia
Enrolled	no. enrolled=209		no. enrolled=209		no. enrolled=209		no. enrolled=209		no. enrolled = 209
Baseline (0)	180	29 excluded	178	31 excluded	176	33 excluded	193	16 excluded	202	7 excluded
Evaluation - treatment
										2 no data
		11 no urine		12 no faeces		12 no faeces		1 no data
										5 invalid data
		13 missed PZQ		14 missed ALB		16 missed PZQ		10 previous treatment
		5 invalid data		5 invalid data		5 invalid data		5 invalid data
1 mo post-treatment (1)	102	78 excluded	110	68 excluded	110	66 excluded	125	68 excluded	133	69 excluded
										63 lost to follow-up
		17 no urine		8 no faeces		8 no faeces		62 lost to follow-up
Evaluation (0)→(1)
										6 invalid data
		58 lost to follow-up		55 lost to follow-up		53 lost to follow-up		6 invalid data
		3 invalid data		5 invalid data		5 invalid data
6 mo post-treatment (6a)	67	35 excluded	67	43 excluded	68	42 excluded	77	48 excluded	82	51 excluded
		29 lost to follow-up		5 no faeces		5 no faeces		44 lost to follow-up		47 lost to follow-up
Evaluation (1)→(6a)		6 invalid data		34 lost to follow-up		34 lost to follow-up		4 invalid data		4 invalid data
Treatment				4 invalid data		3 invalid data
6 mo post-treatment (6b)	92	88 excluded	87	91 excluded	86	90 excluded	100	93 excluded	105	97 excluded
		17 no urine		6 no faeces		6 no faeces		87 lost to follow-up		91 lost to follow-up
Evaluation (0)→(6b)		63 lost to follow-up		82 lost to follow-up		80 lost to follow-up		6 invalid data		6 invalid data
Treatment		8 invalid data		3 invalid data		4 invalid data

ALB, albendazole; PZQ, praziquantel; (0), baseline; (1) 1 mo; (6a), 6 mo after first treatment; (6b), 6 mo after baseline.